{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-292616","form_type":"8-K","ticker":null,"cik":"0001478069","company_name":"CONTRAFECT Corp","filed_at":"2022-11-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.794834+00:00","generated_at":"2026-06-21T13:02:47.168029+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"ContraFect gets Nasdaq deficiency letter; equity -$3.1M vs $2.5M minimum; bid price still deficient","bullets":["Stockholders' equity as of Sept 30, 2022 was $(3.1M), below Nasdaq's $2.5M continued listing requirement.","Company has 45 days (until Jan 6, 2023) to submit a plan to regain compliance with Nasdaq Rule 5550(b)(1).","Prior bid price deficiency from Aug 25, 2022 (below $1.00 for 30 days) remains uncured.","If plan is accepted, Nasdaq may grant up to 180 days (to May 21, 2023) to show compliance.","No immediate effect on trading; company evaluating options but no assurance of regaining compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-292616","json":"https://secwatch.observer/filing/0001193125-22-292616.json","markdown":"https://secwatch.observer/filing/0001193125-22-292616.md","text":"https://secwatch.observer/filing/0001193125-22-292616.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1478069/000119312522292616/0001193125-22-292616-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1478069/000119312522292616/d421710d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T13:02:47.168029+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f5690bb48d26028116f0f246b3adf9d6247ca0ce","claim":"CONTRAFECT Corp received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"a listed company’s stockholders’ equity be at least $2.5 million. As reported on its Form 10-Q, the Company’s stockholders’ equity as of September 30, 2022 was approximately $(3.1) million. The Nasdaq Staff Deficiency Letter has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market which currently trades","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1478069/000119312522292616/0001193125-22-292616-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}